I completely disagree. It is the CEO's and BOD's responsibility to get it right in AU/NZ. What more do you need to understand about the decision to go "SUPER" cost effective small in AU/NZ with the IPF/CC clinical trial? The CEO continues to spew lies while Team Cobra slow rolls a PP dilution scheme right before our eyes. Doc Williams departure IMO proves he wanted out of getting his name ruined by Team Cobra ASAP. His roll was likely never to stick around for the ticking time bomb flop in AU/NZ. Just like the decision flop in SK but quicker. WE LOST A MILLION DOLLARS IN THAT SK FLOP. Also, CJM told us the newly appointed VP & CMO was handling all the background business with the clinical trials. So now you want to lay the blame on the scientist (the brain power that built the pipeline) that can't be held to account? Just great!
News 
Market Data 
Discover 
